<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39361667</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>03</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>10</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Respiratory virus behavior: Results of laboratory-based epidemiological surveillance.</ArticleTitle><Pagination><StartPage>e0307322</StartPage><MedlinePgn>e0307322</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0307322</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0307322</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Respiratory viruses have clinical and epidemiological importance. With the COVID-19 pandemic, interest has focused on SARS-CoV-2, but as a result, the number of samples available for the differential diagnosis of other respiratory viruses has increased.</AbstractText><AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">Cross-sectional study.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To describe the epidemiological behavior of respiratory viruses based on a laboratory-based epidemiological surveillance system using data from 2017 to 2023.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Univariate, bivariate and multivariate analyses of data from a laboratory database of respiratory viruses detected by multiplex RT‒qPCR were performed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 4,632 samples with positive results for at least 1 respiratory virus, not including influenza or SARS-CoV-2, were analyzed. The most common virus detected was respiratory syncytial virus in 1,467 (26.3%) samples, followed by rhinovirus in 1,384 (24.8%) samples. Most of the samples were from children under 5 years of age. The age-adjusted odds ratio (OR) of death for patients infected with parainfluenza virus 4 was 4.1 (95% confidence interval [95% CI] 2.0-8.2).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Respiratory syncytial virus and rhinovirus had the highest frequency and proportion of coinfections, whereas parainfluenza virus 4 was associated with an increased risk of death.</AbstractText><CopyrightInformation>Copyright: © 2024 Hernández Bautista et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hernández Bautista</LastName><ForeName>Porfirio Felipe</ForeName><Initials>PF</Initials><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Coordinación de Calidad de Insumos y Laboratorios Especializados, México, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrera Gaytán</LastName><ForeName>David Alejandro</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0001-5314-4786</Identifier><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Coordinación de Calidad de Insumos y Laboratorios Especializados, México, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallejos Parás</LastName><ForeName>Alfonso</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Coordinación de Vigilancia Epidemiológica, México, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moctezuma Paz</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Coordinación de Investigación en Salud, México, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santacruz Tinoco</LastName><ForeName>Clara Esperanza</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Coordinación de Calidad de Insumos y Laboratorios Especializados, México, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alvarado Yaah</LastName><ForeName>Julio Elias</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Coordinación de Calidad de Insumos y Laboratorios Especializados, México, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anguiano Hernández</LastName><ForeName>Yu Mei</ForeName><Initials>YM</Initials><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Coordinación de Calidad de Insumos y Laboratorios Especializados, México, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martínez Miguel</LastName><ForeName>Bernardo</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Coordinación de Calidad de Insumos y Laboratorios Especializados, México, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arriaga Nieto</LastName><ForeName>Lumumba</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Coordinación de Vigilancia Epidemiológica, México, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaimes Betancourt</LastName><ForeName>Leticia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Unidad de Medicina Familiar No. 7, México, México.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandoval Gutiérrez</LastName><ForeName>Nancy</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Instituto Mexicano del Seguro Social, Coordinación de Calidad de Insumos y Laboratorios Especializados, México, México.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012141" MajorTopicYN="Y">Respiratory Tract Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062665" MajorTopicYN="N">Epidemiological Monitoring</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="N">Coinfection</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018357" MajorTopicYN="N">Respiratory Syncytial Virus Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>7</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>13</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39361667</ArticleId><ArticleId IdType="pmc">PMC11449343</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0307322</ArticleId><ArticleId IdType="pii">PONE-D-23-43288</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Centers for Disease Control and Prevention. National Center for Immunization and Respiratory Diseases. Children with Hepatitis of Unknown Cause. USA: CDC: June
7
2022. Available from: https://www.cdc.gov/ncird/investigation/hepatitis-unknown-cause/overview-what-to-know.html</Citation></Reference><Reference><Citation>Biggs HM, Lu X, Dettinger L, Sakthivel S, Watson JT, Boktor SW. Adenovirus-Associated Influenza-Like Illness among College Students, Pennsylvania, USA. Emerg Infect Dis. 2018;24(11):2117–9. doi: 10.3201/eid2411.180488</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2411.180488</ArticleId><ArticleId IdType="pmc">PMC6199975</ArticleId><ArticleId IdType="pubmed">30334721</ArticleId></ArticleIdList></Reference><Reference><Citation>Marsh K, Tayler R, Pollock L, Roy K, Lakha F, Ho A, et al.. Investigation into cases of hepatitis of unknown aetiology among young children, Scotland, 1 January 2022 to 12 April 2022. Euro Surveill. 2022;27(15):2200318. doi: 10.2807/1560-7917.ES.2022.27.15.2200318</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.15.2200318</ArticleId><ArticleId IdType="pmc">PMC9012090</ArticleId><ArticleId IdType="pubmed">35426362</ArticleId></ArticleIdList></Reference><Reference><Citation>UK Health Security Agency. Increase in hepatitis (liver inflammation) cases in children under investigation. UK: UK Health Security Agency; 6
April
2022. Available from: https://www.gov.uk/government/news/increase-in-hepatitis-liver-inflammation-cases-in-children-under-investigation</Citation></Reference><Reference><Citation>van Beek J, Fraaij P, Giaquinto C, Shingadia D, Horby P, Indolfi G, Acute hepatitis study group. Case numbers of acute hepatitis of unknown aetiology among children in 24 countries up to 18 April 2022 compared to the previous 5 years. Euro Surveill. 2022;27(19):2200370. doi: 10.2807/1560-7917.ES.2022.27.19.2200370</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.19.2200370</ArticleId><ArticleId IdType="pmc">PMC9101970</ArticleId><ArticleId IdType="pubmed">35551703</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker JM, Buchfellner M, Britt W, Sanchez V, Potter JL, Ingram LA, et al.. Acute Hepatitis and Adenovirus Infection Among Children—Alabama, October 2021–February 2022. MMWR Morb Mortal Wkly Rep 2022;71:638–40. doi: 10.15585/mmwr.mm7118e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7118e1</ArticleId><ArticleId IdType="pmc">PMC9098244</ArticleId><ArticleId IdType="pubmed">35511732</ArticleId></ArticleIdList></Reference><Reference><Citation>Government of Canada. Respiratory Virus Report, Week 19—ending May 14, 2022. Available from: https://www.canada.ca/en/public-health/services/surveillance/respiratory-virus-detections-canada/2021-2022/week-19-ending-may-14-2022.html#a8</Citation></Reference><Reference><Citation>European Centre for Disease Prevention and Control/WHO Regional Office for Europe. Hepatitis of Unknown Aetiology in Children, Joint Epidemiological overview, 20 May, 2022. ECDC/WHO; 25 November 2022. Available from: https://cdn.ecdc.europa.eu/novhep-surveillance/</Citation></Reference><Reference><Citation>Secretaría de Salud. Manual para la vigilancia epidemiológica de influenza. México: Secretaría de Salud; October 2014.</Citation></Reference><Reference><Citation>Secretaría de Salud. Lineamiento estandarizado para la vigilancia epidemiológica y por laboratorio de la enfermedad respiratoria viral. México: Secretaría de Salud; April 2022. Available from: https://www.gob.mx/cms/uploads/attachment/file/715464/Lineamiento_VE_y_Lab_Enf_Viral_05042022.pdf</Citation></Reference><Reference><Citation>Secretaría de Salud. Listado de laboratorios que realizan el diagnóstico de SARS-CoV-2. México: Secretaría de Salud; last updated February 2022. Available from: https://www.gob.mx/salud/documentos/coronavirus-covid-19-240014</Citation></Reference><Reference><Citation>Moe N, Pedersen B, Nordbø SA, Skanke LH, Krokstad S, Smyrnaios A, et al.. Respiratory Virus Detection and Clinical Diagnosis in Children Attending Day Care. PLoS One. 2016. Jul 19;11(7):e0159196. doi: 10.1371/journal.pone.0159196</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0159196</ArticleId><ArticleId IdType="pmc">PMC4951077</ArticleId><ArticleId IdType="pubmed">27433803</ArticleId></ArticleIdList></Reference><Reference><Citation>Kesson AM. Respiratory virus infections. Paediatr Respir Rev. 2007;8(3):240–8. doi: 10.1016/j.prrv.2007.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prrv.2007.07.003</ArticleId><ArticleId IdType="pmc">PMC7106180</ArticleId><ArticleId IdType="pubmed">17868922</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Li Y, Deloria-Knoll M, Madhi SA, Cohen C, Arguelles VL, et al.. Global burden of acute lower respiratory infection associated with human parainfluenza virus in children younger than 5 years for 2018: a systematic review and meta-analysis. Lancet Glob Health. 2021. Aug;9(8):e1077–e1087. doi: 10.1016/S2214-109X(21)00218-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(21)00218-7</ArticleId><ArticleId IdType="pmc">PMC8298256</ArticleId><ArticleId IdType="pubmed">34166626</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu X, Lu R, Wang Z, Zhu N, Wang W, Julian D, et al.. Etiology and clinical characterization of respiratory virus infections in adult patients attending an emergency department in Beijing. PLoS One. 2012;7(2):e32174. doi: 10.1371/journal.pone.0032174 Epub 2012 Feb 28. Erratum in: PLoS One. 2012;7(6). doi: 10.1371/annotation/037611b5-b1fc-40a0-86f3-c9e65a9b90f5 Lv, Jianxin [corrected to Lu, Jianxin].</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0032174</ArticleId><ArticleId IdType="doi">10.1371/annotation/037611b5-b1fc-40a0-86f3-c9e65a9b90f5</ArticleId><ArticleId IdType="pmc">PMC3289638</ArticleId><ArticleId IdType="pubmed">22389685</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito S, Mencacci A, Cenci E, Camilloni B, Silvestri E, Principi N. Multiplex Platforms for the Identification of Respiratory Pathogens: Are They Useful in Pediatric Clinical Practice? Front Cell Infect Microbiol. 2019. Jun 4;9:196. doi: 10.3389/fcimb.2019.00196</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2019.00196</ArticleId><ArticleId IdType="pmc">PMC6593267</ArticleId><ArticleId IdType="pubmed">31275863</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Luo Q, Gong C, Li AH, Dong M, Zhang H, et al.. Prospective surveillance of human adenovirus in acute respiratory infections reveals epidemiological features and the disappearance of species B during the COVID-19 pandemic in Beijing, China. J Infect. 2022. Oct;85(4):436–480. doi: 10.1016/j.jinf.2022.07.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2022.07.015</ArticleId><ArticleId IdType="pmc">PMC9446110</ArticleId><ArticleId IdType="pubmed">35878683</ArticleId></ArticleIdList></Reference><Reference><Citation>Maleki A, Mehrbod P, Bokharaei-Salim F, Eybpoosh S, Tavakoli M, Mohammadnejad AE, et al.. Epidemiological surveillance of respiratory viral infections in SARS-CoV-2-negative samples during COVID-19 pandemic in Iran. Virol J. 2023. Dec 13;20(1):296. doi: 10.1186/s12985-023-02226-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-02226-5</ArticleId><ArticleId IdType="pmc">PMC10720196</ArticleId><ArticleId IdType="pubmed">38093303</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention. RSV National Trends. USA: CDC; updated May 3 2023. Available from: https://www.cdc.gov/surveillance/nrevss/rsv/natl-trend.html</Citation></Reference><Reference><Citation>Secretaría de Salud. Informe semanal de casos de Hepatitis Grave Aguda de causa desconocida. México: Secretaría de Salud; 2023. Available from: https://www.gob.mx/salud/acciones-y-programas/informes-semanales-para-la-vigilancia-epidemiologica-2023</Citation></Reference><Reference><Citation>De Jacobis IT, Vona R, Straface E, Gambardella L, Ceglie G, de Gennaro F, et al.. Sex differences in blood pro-oxidant status and platelet activation in children admitted with respiratory syncytial virus bronchiolitis: a pilot study. Ital J Pediatr. 2020. Mar 6;46(1):29. doi: 10.1186/s13052-020-0792-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13052-020-0792-x</ArticleId><ArticleId IdType="pmc">PMC7059674</ArticleId><ArticleId IdType="pubmed">32143677</ArticleId></ArticleIdList></Reference><Reference><Citation>Toivonen L, Camargo CA Jr, Gern JE, Bochkov YA, Mansbach JM, Piedra PA, et al.. Association between rhinovirus species and nasopharyngeal microbiota in infants with severe bronchiolitis. J Allergy Clin Immunol. 2019. May;143(5):1925–1928.e7. doi: 10.1016/j.jaci.2018.12.1004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2018.12.1004</ArticleId><ArticleId IdType="pmc">PMC6504611</ArticleId><ArticleId IdType="pubmed">30654045</ArticleId></ArticleIdList></Reference><Reference><Citation>Li F, Zhang Y, Shi P, Cao L, Su L, Fu P, et al.. Mycoplasma pneumoniae and Adenovirus Coinfection Cause Pediatric Severe Community-Acquired Pneumonia. Microbiol Spectr. 2022. Apr 27;10(2):e0002622. doi: 10.1128/spectrum.00026-22</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.00026-22</ArticleId><ArticleId IdType="pmc">PMC9045297</ArticleId><ArticleId IdType="pubmed">35311565</ArticleId></ArticleIdList></Reference><Reference><Citation>Calvo C, García-García ML, Pozo F, Paula G, Molinero M, Calderón A, et al.. Respiratory Syncytial Virus Coinfections With Rhinovirus and Human Bocavirus in Hospitalized Children. Medicine (Baltimore). 2015. Oct;94(42):e1788. doi: 10.1097/MD.0000000000001788</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000001788</ArticleId><ArticleId IdType="pmc">PMC4620789</ArticleId><ArticleId IdType="pubmed">26496310</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos N, Vankeerberghen A, Vaeyens F, Van Vaerenbergh K, Boel A, De Beenhouwer H. Simultaneous detection of human bocavirus and adenovirus by multiplex real-time PCR in a Belgian paediatric population. Eur J Clin Microbiol Infect Dis. 2009. Nov;28(11):1305–10. doi: 10.1007/s10096-009-0780-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-009-0780-y</ArticleId><ArticleId IdType="pmc">PMC7087762</ArticleId><ArticleId IdType="pubmed">19705175</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin CY, Hwang D, Chiu NC, Weng LC, Liu HF, Mu JJ, et al.. Increased Detection of Viruses in Children with Respiratory Tract Infection Using PCR. Int J Environ Res Public Health. 2020. Jan 15;17(2):564. doi: 10.3390/ijerph17020564</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17020564</ArticleId><ArticleId IdType="pmc">PMC7013517</ArticleId><ArticleId IdType="pubmed">31952364</ArticleId></ArticleIdList></Reference><Reference><Citation>Debiaggi M, Canducci F, Ceresola ER, Clementi M. The role of infections and coinfections with newly identified and emerging respiratory viruses in children. Virol J. 2012. Oct 27;9:247. doi: 10.1186/1743-422X-9-247</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-247</ArticleId><ArticleId IdType="pmc">PMC3573994</ArticleId><ArticleId IdType="pubmed">23102237</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida LM, Suzuki M, Nguyen HA, Le MN, Dinh Vu T, Yoshino H, et al.. Respiratory syncytial virus: co-infection and paediatric lower respiratory tract infections. Eur Respir J. 2013. Aug;42(2):461–9. doi: 10.1183/09031936.00101812</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/09031936.00101812</ArticleId><ArticleId IdType="pubmed">23645407</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuta K, Abiko C, Aoki Y, Ikeda T, Itagaki T, Katsushima F, et al.. Epidemiology of parainfluenza virus types 1, 2 and 3 infections based on virus isolation between 2002 and 2011 in Yamagata, Japan. Microbiology and Immunology, 2012;56: 855–858. doi: 10.1111/j.1348-0421.2012.00507.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1348-0421.2012.00507.x</ArticleId><ArticleId IdType="pubmed">22946520</ArticleId></ArticleIdList></Reference><Reference><Citation>Glezen WP, Greenberg SB, Atmar RL, Piedra PA, Couch RB. Impact of respiratory virus infections on persons with chronic underlying conditions. JAMA 2000; 283 (4) 499–50531. doi: 10.1001/jama.283.4.499</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.283.4.499</ArticleId><ArticleId IdType="pubmed">10659876</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Stelzer-Braid S, Scotch M, Rawlinson WD. Detection of respiratory viruses directly from clinical samples using next-generation sequencing: A literature review of recent advances and potential for routine clinical use. Rev Med Virol. 2022. Sep;32(5):e2375. doi: 10.1002/rmv.2375</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2375</ArticleId><ArticleId IdType="pmc">PMC9539958</ArticleId><ArticleId IdType="pubmed">35775736</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu G, Xu D, Zhang Y, Wang T, Zhang L, Gu W, et al.. Epidemiological characteristics of four common respiratory viral infections in children. Virol J. 2021. Jan 6;18(1):10. doi: 10.1186/s12985-020-01475-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-020-01475-y</ArticleId><ArticleId IdType="pmc">PMC7787583</ArticleId><ArticleId IdType="pubmed">33407659</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes-Matano L, Monroy-Muñoz IE, Angeles-Martínez J, Sarquiz-Martinez B, Palomec-Nava ID, Pardavé-Alejandre HD, et al.. Prevalence of non-influenza respiratory viruses in acute respiratory infection cases in Mexico. PLoS One. 2017. May 3;12(5):e0176298. doi: 10.1371/journal.pone.0176298</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0176298</ArticleId><ArticleId IdType="pmc">PMC5415110</ArticleId><ArticleId IdType="pubmed">28467515</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedroza-Uribe IM, Vega Magaña N, Muñoz-Valle JF, Peña-Rodriguez M, Carranza-Aranda AS, Sánchez-Sánchez R, et al.. Beyond SARS-CoV-2: epidemiological surveillance of respiratory viruses in Jalisco, Mexico. Front Public Health. 2024. Jan 11;11:1292614. doi: 10.3389/fpubh.2023.1292614</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1292614</ArticleId><ArticleId IdType="pmc">PMC10808461</ArticleId><ArticleId IdType="pubmed">38274524</ArticleId></ArticleIdList></Reference><Reference><Citation>Shieh WJ. Human adenovirus infections in pediatric population—An update on clinico-pathologic correlation. Biomed J. 2022;45(1):38–49. doi: 10.1016/j.bj.2021.08.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bj.2021.08.009</ArticleId><ArticleId IdType="pmc">PMC9133246</ArticleId><ArticleId IdType="pubmed">34506970</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>